Overview
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 1, 2025 | Implantica announces publication of the landmark RefluxStop® 5-year clinical study results demonstrating excellent long-term success | Implantica announces publication of the landmark RefluxStop® 5-year clinical study results demonstrating excellent long-term success Tue, Jul 01, 2025 08:00 CET Report this content Implantica AG (publ.), a medtech company at the forefront o... |
| Aug 21, 2024 | New Frontiers in Medical Technology: RefluxStop™ and Type 1 Diabetes Awareness | In the ever-evolving landscape of medical technology, two recent developments stand out: the promising results of the RefluxStop™ device and the launch of the "Detect So You Can Decide" campaign by Breakthrough T1D. Both initiativ... |
| Aug 20, 2024 | Implantica announces RefluxStop™ pivotal 4-year study results published in the prestigious journal Surgical Endoscopy | Implantica announces RefluxStop™ pivotal 4-year study results published in the prestigious journal Surgical Endoscopy Tue, Aug 20, 2024 08:00 CET Report this content Implantica AG (publ.), a medtech company at the forefront of introducing a... |
| Apr 12, 2023 | AssistIQ is SAGES 2023 Shark Tank Winner | Shark Tank Winner 2023 AssistIQ's Lisa Israelovitch with Shark Tank host Dr. Christopher Schlachta and Shark Tank Judge Dr. Steven Schwaitzberg AI Supply Capture and Intelligence Platform Reduces Supply Waste, Costs and Carbon Footprint The... |
| Aug 12, 2021 | Johnson & Johnson : Ethicon's Echelon Circular Powered Stapler Associated With Major Reduction In Serious Complications Following Colorectal Surgery | New Real-World Study Shows 74% Decrease In Anastomotic Leaks Compared To Manual Staplers, Reinforcing Findings From Previous Clinical Studies Cinncinnati, OH - Aug. 11, 2021 - Ethicon*, part of the Johnson & Johnson Medical Devices Comp... |
| Sep 27, 2012 | The Next Big Niche? Emerging Med-Tech for Transplant. | As an advisor to emerging med tech companies, I am always on the lookout for attractive niche markets where new technologies might get a foothold and demonstrate their value before taking on the (often mythical) billion-dollar opportunity. ... |
| May 18, 2010 | Simbionix USA looks for productive ways to harness ‘data exhaust’ | Jensen also could be the one to create new revenue for Simbionix by harnessing some of the data the company — and others — generate to drive medical product development and clinical trial design. “I’ve worked for some of the largest informa... |
| Apr 12, 2010 | Mederi launches Stretta GERD treatment in the U.S. | Ten years after it first won clearance from the Food & Drug Administration, Mederi Therapeutics Inc.’s Stretta treatment for gastro-esophageal reflux disease is hitting the market in the U.S. CEO Will Rutan told MassDevice that the syst... |
| Simbionix USA looks for productive ways to harness ‘data exhaust’ | Updated 7:08 p.m. Information has been the main course on Paul Jensen’s professional plate for most of his career. Add a generous portion of product technology and education experience, and you get someone who seems ideal to help Simbionix ... |
Reviews 0
FAQ about Welcome to SAGES
What has the press written about Welcome to SAGES?
Parsers VC has collected 11 articles mentioning Welcome to SAGES, among them “Implantica announces publication of the landmark RefluxStop® 5-year clinical study results demonstrating excellent long-term success” (Jul 1, 2025) and “New Frontiers in Medical Technology: RefluxStop™ and Type 1 Diabetes Awareness” (Aug 21, 2024).
Is Welcome to SAGES still active?
Welcome to SAGES is probably closed: its latest activity on Parsers VC dates from Aug 7, 2025.